Fintel on MSN

HC Wainwright & Co. initiates coverage of Jade Biosciences (JBIO) with buy recommendation

Fintel reports that on January 7, 2026, HC Wainwright & Co. initiated coverage of Jade Biosciences (NasdaqCM:JBIO) with a Buy ...
Nasdaq

Jade Biosciences (JBIO) Price Target Increased by 13.43% to 19.38

The average one-year price target for Jade Biosciences (NasdaqCM:JBIO) has been revised to $19.38 / share. This is an increase of 13.43% from the prior estimate of $17.08 dated September 27, 2025. The ...

Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week

Key Insights Institutions' substantial holdings in Jade Biosciences implies that they have significant influence ...
Benzinga.com

Jade Biosciences Analyst Ratings

The latest price target for Jade Biosciences (NASDAQ:JBIO) was reported by Clear Street on November 25, 2025. The analyst firm set a price target for $25.00 expecting JBIO to rise to within 12 months ...